Cost Effectiveness of Human Papillomavirus Vaccination for Men Who have Sex with Men; Reviewing the Available Evidence.

Didik SetiawanAbrham WondimuKohJun OngAlbert Jan van HoekMaarten J Postma

Published in: PharmacoEconomics (2019)

This review presents the human papillomavirus vaccine, both as a primary and adjuvant (tertiary) vaccination, as a potentially cost-effective strategy for preventing mainly-but not limited to only-anal cancer in men-who-have-sex-with-men populations.

Keyphrases

men who have sex with men
hiv testing
hiv positive
papillary thyroid
early stage
squamous cell
high grade
squamous cell carcinoma
young adults
genetic diversity
hepatitis c virus
hiv infected